Broadcasting News

Kim Min-ha, Who Lost 17 kg, Opens the Blue Dragon Series Awards… with a Mesmerizing Jazz Performance

The 5th Blue Dragon Series Awards Song Selection for "That's Life" Making Headlines After Recently Losing 17 kg

Gim Ga Yeong
2026-07-31 20:48:02
[Edaily Starin Gim Ga Yeong Reporter] Actress Kim Min-ha delivered a captivating jazz performance.
Kim Min-ha took the stage for the opening performance at the 5th Blue Dragon Series Awards, held on the afternoon of the 31st at Paradise City in Incheon.
Kim Min-ha selected the jazz song “That’s Life” and delivered a captivating performance. Her strong vocal skills stood out.
Kim Min-ha recently made headlines by revealing that she had lost a total of 17 kg over the course of two years, and she drew attention by showcasing her slender figure in a silver dress.
Meanwhile, Kim Min-ha previously won the Best Newcomer Award at the 4th Blue Dragon Series Awards for her role in the TVING series *A Week Before I Die*.
The Blue Dragon Series Awards is Korea’s first awards ceremony dedicated to streaming series content. The nominees, announced earlier, were selected from dramas and variety shows released on domestic and international streaming platforms between June 1 of last year and May 31 of this year.

Economy

Corporation

IT·Science

Economy

"AI Broadcasts on Its Own"... A Creator Startup Founded by a Former TikTok Employee [VC Cradle]

A virtual creator that doesn’t require a human actor has emerged. There is no pre-written script, nor is there an operator manipulating it in real time. Artificial intelligence (AI) hosts the broadcas…
2026-08-08 11:01:04

Corporation

Mezzion Pharma Co., Ltd. Simultaneously Improves Cysts and Kidney Function in ADPKD… “Moving Directly to Phase 2b Clinical Trials in Korea and the U.S.”

“When you examine the kidneys of mice with polycystic kidney disease, you can see large cysts. However, after administering Udenafil, a reduction in the size of these cysts was visible even to the nak…
2026-08-08 08:16:01

IT·Science

SK BIOPHARMACEUTICALS Soars on Cenobamate Growth… The Era of 45% Generic Drug Prices Begins [Weekly Bio Roundup]

(Graphic: Generative AI) During the first week of August (August 3–7), SK BIOPHARMACEUTICALS posted its best-ever quarterly earnings, driven by the growth of its new epilepsy drug “cenobamate.” Ad…
2026-08-08 08:31:03